| Molecular and neuronal substrates for general anaesthetics U Rudolph, B Antkowiak Nature Reviews Neuroscience 5 (9), 709-720, 2004 | 900 | 2004 |
| General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit R Jurd, M Arrasa, S Lambert, B Drexler, R Siegwart, F Crestani, M Zaugg, ... The FASEB Journal 17 (2), 250-252, 2003 | 697 | 2003 |
| Different Actions of General Anesthetics on the Firing Patterns of Neocortical Neurons Mediated by the GABAAReceptor B Antkowiak The Journal of the American Society of Anesthesiologists 91 (2), 500-511, 1999 | 207 | 1999 |
| Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABAA receptor‐mediated inhibition H Hentschke, C Schwarz, B Antkowiak European Journal of Neuroscience 21 (1), 93-102, 2005 | 206 | 2005 |
| Molecular and systemic mechanisms of general anaesthesia: the ‘multi-site and multiple mechanisms’ concept C Grasshoff, U Rudolph, B Antkowiak Current Opinion in Anesthesiology 18 (4), 386-391, 2005 | 159 | 2005 |
| How do general anaesthetics work? B Antkowiak Naturwissenschaften 88, 201-213, 2001 | 143 | 2001 |
| Anaesthetic drugs: linking molecular actions to clinical effects C Grasshoff, B Drexler, U Rudolph, B Antkowiak Current pharmaceutical design 12 (28), 3665-3679, 2006 | 124 | 2006 |
| Propofol and Sevoflurane Depress Spinal Neurons In Vitro via Different Molecular Targets C Grasshoff, B Antkowiak The Journal of the American Society of Anesthesiologists 101 (5), 1167-1176, 2004 | 112 | 2004 |
| Effects of isoflurane and enflurane on GABAA and glycine receptors contribute equally to depressant actions on spinal ventral horn neurones in rats C Grasshoff, B Antkowiak BJA: British Journal of Anaesthesia 97 (5), 687-694, 2006 | 88 | 2006 |
| In vitro networks: cortical mechanisms of anaesthetic action B Antkowiak British journal of anaesthesia 89 (1), 102-111, 2002 | 81 | 2002 |
| Effects of small concentrations of volatile anesthetics on action potential firing of neocortical neurons in vitro B Antkowiak, C Helfrich-Forster The Journal of the American Society of Anesthesiologists 88 (6), 1592-1605, 1998 | 69 | 1998 |
| Effects of the Volatile Anesthetic Enflurane on Spontaneous Discharge Rate and GABAA-Mediated Inhibition of Purkinje Cells in Rat Cerebellar Slices B Antkowiak, D Heck Journal of Neurophysiology 77 (5), 2525-2538, 1997 | 51 | 1997 |
| Oscillations of the Membrane Potential of Pulvinar Motor Cells In Situ in Relation to Leaflet Movements of Desmodium motorium B Antkowiak, WE Mayer, W Engelmann Journal of experimental botany 42 (7), 901-910, 1991 | 48 | 1991 |
| Cellular mechanisms of gamma rhythms in rat neocortical brain slices probed by the volatile anaesthetic isoflurane B Antkowiak, H Hentschke Neuroscience letters 231 (2), 87-90, 1997 | 46 | 1997 |
| Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms B Drexler, S Zinser, H Hentschke, B Antkowiak Anesthesia & Analgesia 111 (6), 1394-1399, 2010 | 44 | 2010 |
| Cross-approximate entropy of cortical local field potentials quantifies effects of anesthesia-a pilot study in rats M Kreuzer, H Hentschke, B Antkowiak, C Schwarz, EF Kochs, ... BMC neuroscience 11, 1-11, 2010 | 43 | 2010 |
| Inhibitory ligand-gated ion channels as substrates for general anesthetic actions A Zeller, R Jurd, S Lambert, M Arras, B Drexler, C Grashoff, B Antkowiak, ... Modern Anesthetics, 31-51, 2008 | 40 | 2008 |
| Oscillations of apoplasmic K+ and H+ activities in Desmodium motorium (Houtt.) Merril. pulvini in relation to the membrane potential of motor cells and leaflet movements B Antkowiak, W Engelmann Planta 196 (2), 350-356, 1995 | 39 | 1995 |
| Organotypic cultures as tools for testing neuroactive drugs-link between in-vitro and in-vivo experiments B Drexler, H Hentschke, B Antkowiak, C Grasshoff Current medicinal chemistry 17 (36), 4538-4550, 2010 | 38 | 2010 |
| GABA (A) receptor-targeted drug development-New perspectives in perioperative anesthesia B Antkowiak, G Rammes Expert opinion on drug discovery 14 (7), 683-699, 2019 | 35 | 2019 |
